HL7 Terminology (THO)
5.4.0 - Publication
This page is part of the HL7 Terminology (v5.4.0: Release) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Official URL: http://terminology.hl7.org/ValueSet/v3-MedicationGeneralizationRoleType | Version: 3.0.0 | |||
Active as of 2014-03-26 | Responsible: Health Level Seven International | Computable Name: MedicationGeneralizationRoleType | ||
Other Identifiers: id: Uniform Resource Identifier (URI)#urn:oid:2.16.840.1.113883.1.11.19720 | ||||
Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license |
Identifies the specific hierarchical relationship between the playing and scoping medications.
Examples: Generic, Generic Formulation, Therapeutic Class, etc.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v3-RoleCode
where concept is-a _MedicationGeneralizationRoleType
This value set contains 6 concepts
Expansion based on codesystem RoleCode v3.0.0 (CodeSystem)
Level | Code | System | Display | Definition |
1 | _MedicationGeneralizationRoleType | http://terminology.hl7.org/CodeSystem/v3-RoleCode | MedicationGeneralizationRoleType | Identifies the specific hierarchical relationship between the playing and scoping medications. Examples: Generic, Generic Formulation, Therapeutic Class, etc. |
2 | DC | http://terminology.hl7.org/CodeSystem/v3-RoleCode | therapeutic class | **Description:**A categorization of medicinal products by their therapeutic properties and/or main therapeutic use. |
2 | GD | http://terminology.hl7.org/CodeSystem/v3-RoleCode | generic drug | Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients independent of strength, and form. The scoping entity identifies a unique combination of medicine ingredients; sometimes referred to as "ingredient set". |
3 | GDF | http://terminology.hl7.org/CodeSystem/v3-RoleCode | generic drug form | Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients and dose form, independent of strength of the ingredients. The scoping entity identifies a unique combination of medicine ingredients in a specific dose form. |
3 | GDS | http://terminology.hl7.org/CodeSystem/v3-RoleCode | generic drug strength | Relates a manufactured drug product to the non-proprietary (generic) representation of is ingredients with their strength. The scoping entity identifies a unique combination of medicine ingredients with their strength. |
3 | GDSF | http://terminology.hl7.org/CodeSystem/v3-RoleCode | generic drug strength form | Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form. |
2 | MGDSF | http://terminology.hl7.org/CodeSystem/v3-RoleCode | manufactured drug strength form | Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form. |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |
History
Date | Action | Author | Custodian | Comment |
2023-11-14 | revise | Marc Duteau | TSMG | Add standard copyright and contact to internal content; up-476 |
2022-10-18 | revise | Marc Duteau | TSMG | Fixing missing metadata; up-349 |
2020-05-06 | revise | Ted Klein | Vocabulary WG | Migrated to the UTG maintenance environment and publishing tooling. |
2014-03-26 | revise | Vocabulary (Woody Beeler) (no record of original request) | 2014T1_2014-03-26_001283 (RIM release ID) | Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 |